NCT05890898

Brief Summary

Two groups of pediatric patients between the ages of 4 to 12 years old will be examined in this study. Control group will receive the standard of care dental treatment with under nitrous sedation (N2O) and will have a second visit where Virtual Reality(VR) goggles will be used instead of N2O. The treatment group will receive the standard of care dental treatment with VR googles first and will have a second visit where N2O will be used instead of VR. Procedures performed in all groups will be restorative treatments, which can include intraoral anesthetic injections, placing dental fillings, crowns, and the extractions of teeth. In group 1, A specific VR headset, the "Oculus Quest 2" will be used. Through the headset, a video will be played for the child during a dental procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 6, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

September 19, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2024

Completed
Last Updated

September 26, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

May 3, 2023

Last Update Submit

September 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Rate of effectiveness virtual reality goggles reduce pain

    To determine whether the use of distraction via virtual reality headset can be as effective as nitrous oxide for purposes of anxiolysis and analgesia during dental treatment. The FLACC scale will be used to help measure this outcome. Patients will be observed during injection and assessed by the operator using the Faces, Legs, Arms, Crying Consolability (FLACC) scale. Each category will be rated from 0 to 2. Zero indicating normal positions and no sign of discomfort and 2 indicating discomfort in movements or unable to console/comfort.

    12 months

  • Rate of effectiveness virtual reality goggles reduce pain

    To determine whether the use of distraction via virtual reality headset can be as effective as nitrous oxide for purposes of anxiolysis and analgesia during dental treatment. The WongBaker scale will be used to help measure this outcome. Patients will rate their pain using the Wong-Baker FACES Pain Scale by indicating which face best depicts the pain they are experiencing. Each face has a corresponding number: 0 = doesn't hurt at all to 10 = hurts as much as you can imagine.

    12 months

Secondary Outcomes (1)

  • Rate of effectiveness of virtual reality distraction to nitrous oxide

    12 months

Study Arms (2)

Control: Nitrous Oxide, then Virtual Reality Goggles

EXPERIMENTAL

Control group will receive the standard of care dental treatment with under nitrous sedation (N2O) and will have a second visit where Virtual Reality(VR) goggles will be used instead of N2O.

Behavioral: Virtual Reality HeadsetDrug: Nitrous Oxide

Treatment: Virtual Reality Goggles, then Nitrous Oxide

EXPERIMENTAL

The treatment group will receive the standard of care dental treatment with VR googles first and will have a second visit under N2O will be used instead of VR.

Behavioral: Virtual Reality HeadsetDrug: Nitrous Oxide

Interventions

To determine if virtual reality headsets can reduce a patients pain level instead of using the standard Nitrous. This may provide a alternate to patients who cannot receive nitrous if pain or anxiety can be reduced effectively.

Control: Nitrous Oxide, then Virtual Reality GogglesTreatment: Virtual Reality Goggles, then Nitrous Oxide

Nitrous Oxide is the current standard of care being used and will be compared to the use of the VR headsets.

Control: Nitrous Oxide, then Virtual Reality GogglesTreatment: Virtual Reality Goggles, then Nitrous Oxide

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Male or female pediatric dental patients age 4-12 years
  • Require two restorative procedures that includes injection of anesthesia
  • American Society of Anesthesiologists (ASA) physical status classification 1 or 2

You may not qualify if:

  • Have health issues that prevent use of VR Oculus headset,
  • Hypersensitivity to audio-visual devices that can lead to seizures
  • ASA physical status classification 3 or 4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger

Danville, Pennsylvania, 17822, United States

Location

MeSH Terms

Interventions

Nitrous Oxide

Intervention Hierarchy (Ancestors)

Nitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2023

First Posted

June 6, 2023

Study Start

September 19, 2023

Primary Completion

July 5, 2024

Study Completion

November 20, 2024

Last Updated

September 26, 2025

Record last verified: 2025-09

Locations